Company intelligence / Profile preview
Tongrui Biopharmaceutical
Chengdu, Sichuan, China
- Ownership
- Private
- Employees
- ~250
- Development stage
- Other
01
Overview
Tongrui Biopharmaceutical (also known as C-Ray Therapeutics) is an innovative Chinese biopharmaceutical company founded in 2021, specializing in the research, development, and commercialization of radiopharmaceuticals. Headquartered in Chengdu with R&D facilities in Shanghai, the company focuses on radionuclide drug conjugates (RDCs) for tumor diagnosis and treatment. Its pipeline includes advanced candidates such as 177Lu-TR0471 for neuroendocrine tumors (Phase 3) and several PSMA-targeted agents for prostate cancer. Beyond its internal pipeline, Tongrui operates as a comprehensive CRDMO, providing services from precursor discovery to cGMP manufacturing. In late 2024, the company secured over $100 million in Series A+ funding to accelerate its global expansion and strengthen its integrated radiopharmaceutical ecosystem.
- Therapeutic areas
- Oncology
- Modalities
- RadiopharmaceuticalRadionuclide drug conjugatePeptide-drug conjugateAntibody-drug conjugateSmall molecule
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
SHINE TechnologiesBiokin Pharmaceutical3SBioTongyi PharmaceuticalTongrun BiologyShuo Microorganisms
Beyond the preview
Go deeper on Tongrui Biopharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tongrui Biopharmaceutical.